Restoring FDA’s Premarket Review Powers
Scholar proposes reforms to address deficiencies in FDA’s premarket review powers.
Ethical Considerations for FDA Accelerated Approval
Scholars debate ways to improve FDA’s accelerated approval mechanism.
Underrepresented, Overmedicated, and Misdiagnosed
Experts contend that FDA clinical trials fail to ensure adequate consideration of women’s health needs.